Michele Senni
Inserm
2 papers in the Anchorcite directory, published between 2020 and 2021, cited 10,679 times in total.
ORCID profileResearch topics
- Diabetes Treatment and Management · 2 papers
- Heart Failure Treatment and Management · 2 papers
- Chronic Kidney Disease and Diabetes · 1 paper
- Cardiovascular Function and Risk Factors · 1 paper
Frequent co-authors
- Milton Packer · 2 papers
- Stefan D. Anker · 2 papers
- Javed Butler · 2 papers
- Gerasimos S Filippatos · 2 papers
- Stuart Pocock · 2 papers
- Peter E. Carson · 2 papers
- James L. Januzzi · 2 papers
- Subodh Verma · 2 papers
Papers
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureNew England Journal of Medicine · 2020 · 5,468 citations
BACKGROUNDSodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes.More evidence is needed regarding the effects of these drugs in patients across the broad spectrum of heart…
- Empagliflozin in Heart Failure with a Preserved Ejection FractionNew England Journal of Medicine · 2021 · 5,211 citations
BACKGROUND: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain. METHODS: In…
Metadata from OpenAlex (CC0).